Cargando…

Polysaccharide-based nanomedicines for cancer immunotherapy: A review

Cancer immunotherapy is an effective antitumor approach through activating immune systems to eradicate tumors by immunotherapeutics. However, direct administration of “naked” immunotherapeutic agents (such as nucleic acids, cytokines, adjuvants or antigens without delivery vehicles) often results in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Yujun, Xiang, Yufan, Sheng, Ruilong, Tomás, Helena, Rodrigues, João, Gu, Zhongwei, Zhang, Hu, Gong, Qiyong, Luo, Kui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005658/ https://www.ncbi.nlm.nih.gov/pubmed/33817416 http://dx.doi.org/10.1016/j.bioactmat.2021.03.008

Ejemplares similares

Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives
por: Shen, Xiaoding, et al.
Publicado: (2023)

Stimuli-activatable nanomedicine meets cancer theranostics
por: Li, Haonan, et al.
Publicado: (2023)

GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine
por: Luo, Lei, et al.
Publicado: (2022)

Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment
por: Cai, Hao, et al.
Publicado: (2021)

Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy
por: Gu, Lei, et al.
Publicado: (2023)

Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)

Application of Nanomedicine in Immunotherapy: Recent Advances and Prospects
por: Longo, João Paulo Figueiró, et al.
Publicado: (2023)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

Polysaccharide-Based Nanomedicines Targeting Lung Cancer
por: Bhat, Asif Ahmad, et al.
Publicado: (2022)

Emerging nanomedicines for effective breast cancer immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2020)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Nanomedicine in Lung Cancer Immunotherapy
por: Doroudian, Mohammad, et al.
Publicado: (2023)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Nanomedicine for Combination Urologic Cancer Immunotherapy
por: Tian, Yun, et al.
Publicado: (2023)

Light-responsive nanomedicine for cancer immunotherapy
por: Kang, Weirong, et al.
Publicado: (2023)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
por: Hagan, C. Tilden, et al.
Publicado: (2020)

Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
por: Chen, Qinjun, et al.
Publicado: (2021)

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
por: Dong, Xiao, et al.
Publicado: (2023)

Nanomedicine sheds new light on cancer immunotherapy
por: Yu, Yingying, et al.
Publicado: (2023)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting
por: Hou, Xingyu, et al.
Publicado: (2021)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020)

Nanomedicine-based immunotherapy for central nervous system disorders
por: Hanif, Sumaira, et al.
Publicado: (2020)

Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
por: Li, Wei, et al.
Publicado: (2020)

Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
por: Peng, Shaojun, et al.
Publicado: (2021)

Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
por: Yang, Yunrong, et al.
Publicado: (2022)

Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2023)

Self‐Stabilized Supramolecular Assemblies Constructed from PEGylated Dendritic Peptide Conjugate for Augmenting Tumor Retention and Therapy
por: Zheng, Xiuli, et al.
Publicado: (2021)

A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody
por: Li, Zhilin, et al.
Publicado: (2022)

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]
por: Li, Zhilin, et al.
Publicado: (2022)

Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy
por: Zhong, Xiao-fang, et al.
Publicado: (2020)

Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
por: Zhu, Yuefei, et al.
Publicado: (2020)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021)

Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy
por: Mpekris, Fotios, et al.
Publicado: (2022)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Enhancing the Efficacy of Metal‐Free MRI Contrast Agents via Conjugating Nitroxides onto PEGylated Cross‐Linked Poly(Carboxylate Ester)
por: Guo, Shiwei, et al.
Publicado: (2020)

Ocular Nanomedicine
por: Tang, Zhimin, et al.
Publicado: (2022)

The solid progress of nanomedicine
por: Martins, João Pedro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n4g5vsokhr7ardnmf42u4ls99h